Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

AAV encoding NUsc1 rescues memory in Alzheimer's disease model

Nov. 8, 2019

Novel gene therapy for the treatment of Alzheimer's disease

Nov. 8, 2019

EIP Pharma releases data from the REVERSE-SD study of neflamapimod

Nov. 8, 2019

Study identifies metabolic path from stress to anxiety

Nov. 8, 2019

Retrotope initiates phase II/III study of RT-001 in Friedreich's ataxia

Nov. 7, 2019

Schizophrenia biomarker can be detected in human hair

Nov. 7, 2019

Dystrogen reports cardioprotective effects of DEC cells in Duchenne muscular dystrophy

Nov. 6, 2019

Small molecules clear mutant Huntingtin protein

Nov. 6, 2019

Enzyme-replacement gene therapy encoding glucocerebrosidase attenuates PD phenotype

Nov. 6, 2019

EOLO-42016 shows promise in model of inherited ALS

Nov. 6, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...